{
    "Trade/Device Name(s)": [
        "Quantia Beta-2 Microglobulin",
        "Quantia Proteins Control",
        "Quantia Beta-2 Microglobulin Standard"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K050613",
    "Predicate Device Reference 510(k) Number(s)": [
        "K943686"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZG",
        "JJS",
        "JJX"
    ],
    "Summary Letter Date": "March 3, 2005",
    "Summary Letter Received Date": "March 10, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5630"
    ],
    "Regulation Name(s)": [
        "Beta-2-microglobulin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Beta-2-microglobulin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AEROSET instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Latex particle enhanced immunoturbidimetric assay",
        "Turbidimetry"
    ],
    "Methodologies": [
        "Immunoturbidimetric quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Standard"
    ],
    "Document Summary": "FDA 510(k) summary for Quantia Beta-2 Microglobulin latex immunoturbidimetric assay, control, and standard for quantitative determination of beta-2-microglobulin in serum or plasma on AEROSET instrument.",
    "Indications for Use Summary": "Intended for quantitative determination of beta-2-microglobulin in human serum or plasma (EDTA) as an aid in diagnosis of active rheumatoid arthritis and kidney disease; control and standard for monitoring quality control and calibration.",
    "fda_folder": "Immunology"
}